The life sciences industry, like many others, has accelerated digital transformation as a result of the global pandemic, among other factors. Creating a digital revolution in healthcare, AI and other technological advancements are changing the customer experience globally – impacting patient treatments and outcomes. Thanks to the explosion of wearable and smart health devices, patients are more connected and have more data than ever before, right at their fingertips. It’s an exciting time in the industry, but certainly presents a new level of challenges.
What types of AI do device manufacturers need to adopt? How do you embrace the change management within your organization? What does this mean in terms of regulatory requirements and the patient outcomes? And how do you manage integrating AI globally, while staying compliant to local regulations?
Join Amplexor for a lively discussion with our panel of experts, Ann Cramer, Director of Digital Product Delivery and Operations at LifeScan; Ilyssa Levins, Regulatory Process Advisor for Digital Health; and Anand Iyer, Chief Strategy Officer at Welldoc as we dig into this topic! We’ll glean crucial knowledge from three key perspectives in the thick of digital transformation in life sciences.